LONDON, Dec 15 (Reuters) - An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said on Friday. Scientists conducted a small trial of people with psychosis and found patients treated with CBD had lower levels of ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment